The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Saved in:
| Title: | The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. |
|---|---|
| Authors: | Cook G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Royle KL; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., O'Connor S; HMDS, Leeds Teaching Hospitals Trust, Leeds, UK., Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Ashcroft AJ; Mid-Yorkshire NHS Trust, Wakefield, UK., Williams CD; Department of Haematology, Centre for Clinical Haematology, Nottingham City Hospitals, Nottingham, UK., Hockaday A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Cavenagh JD; Department of Haematology, Barts & The London NHS Trust, London, UK., Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Ademokun D; Ipswich Hospital NHS Trust, Ipswich, UK., Tholouli E; Department of Haematology, Manchester Royal Infirmary, Manchester, UK., Andrews VE; Medway Maritime Hospital, Kent, UK., Jenner M; University Hospital Southampton NHS Foundation, Southampton, UK., Parrish C; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Yong K; Department of Haematology, University College Hospital, London, UK., Cavet J; Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK., Hunter H; Department of Haematology, Plymouth Hospitals Trust, Plymouth, UK., Bird JM; Department of Haematology, University Hospitals Bristol NHS Trust, Bristol, UK., Pratt G; Department of Haematology, Heart of England NHS Trust, Birmingham, UK., Drayson MT; University of Birmingham, Birmingham, UK., Brown JM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Morris TCM; Queen's University, Belfast, UK. |
| Corporate Authors: | National Cancer Research Institute Haemato-oncology Clinical Studies Group |
| Source: | British journal of haematology [Br J Haematol] 2019 May; Vol. 185 (3), pp. 450-467. Date of Electronic Publication: 2019 Feb 06. |
| Publication Type: | Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.15782 |
